BSE filing, NSE: METROPOLIS. Summary written from the filing by ALFA Finder's alert engine.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹551.20
- Market cap
- ₹11,435 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 56.7×Sector 52.0×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Metropolis Healthcare Other Announcement
Metropolis Healthcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides details on the company's equity share distribution.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 9,516 equity shares under its RSU Plan, 2020. This issuance follows the exercise of vested stock units by employees.
Metropolis Healthcare Other Announcement
Metropolis Healthcare filed the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Metropolis Healthcare Business Update
Metropolis Healthcare provided a business update for Q2FY27, reporting 15% Y-o-Y revenue growth driven by increased patient and test volumes alongside improved EBITDA margins.
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare allotted 66,312 equity shares to employees under its RSU Plan, 2020. This exercise follows the vesting of RSUs previously granted to staff.
Other board meeting date announcements
All →TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.
RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.